Clinical trial
SCI-Pex, a Multi-center, Prospective, Non-controlled Investigation to Evaluate the Safety and Performance of PexyEazy®, a Device for Treatment of Hemorrhoids
NCT05782010 is registered in ClinicalTrials.gov with Developeration AB as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- SCI-Pex, a Multi-center, Prospective, Non-controlled Investigation to Evaluate the Safety and Performance of PexyEazy®, a Device for Treatment of Hemorrhoids
- Lead sponsor
- Developeration AB
- Phase
- Not applicable
- Overall status
- Recruiting
- Start date
- June 15, 2023
- Completion date
- May 30, 2026
- Enrollment
- 35 (estimated)
- Sites
- 3
Conditions
As the registry lists them; a condition with its own page is linked.
gastrointestinal diseases, hemorrhoids, hemorrhoids, internal, rectal diseases, suture; complications, infection or inflammation